SCHEDULE 13D/A//SEC Filing
Chemomab Therapeutics Ltd. SCHEDULE 13D/A
Accession 0000947871-25-000624
CIK 0001569821other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:06 PM ET
Size
27.1 KB
Accession
0000947871-25-000624
Issuer
OrbiMed Israel BioFund GP Limited Partnership
CIK 0001569821
Entity typeother
IncorporatedIsrael
Related Parties
1- filerCIK 0001569821
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 5:06 PM ET
- Size
- 27.1 KB